• New Delhi
  • 24 November 2014
  • Interviews
  • By Rahul Koul

"Antibiotic resistance is a serious threat"

Besides better regulations, there is a need to increase the role of private sector, Dr BR Das, president - Research and Innovation, Mentor - Molecular Pathology and Clinical Research Service, SRL Diagnostics told BioSpectrum in an an e-interview

dr-b-r-das-srl-diagnostics

Dr BR Das, president - Research and Innovation, Mentor - Molecular Pathology and Clinical Research Service, SRL Diagnostics.

Q: How do you look at the growing threat of anti-microbial resistance? It is really as alarming as perceived?

Antimicrobial resistance till date is most often associated with nosocomial infections (hospital based infections), and reports on these are limited in India. But there have been reports on emergence of superbug, NDM-1 which in itself is a disaster as it is resistant to even high-end drugs like carbapenems.

We being a private diagnostic setup and based on our internal data, would be considered as community acquired AMR data also seems worrisome. High level and continuously increasing levels of resistance has been noted for most of the gram negative and gram positive organisms. Yes, such data hints at the seriousness of the issue and should be considered as a threat. 

Q: What are the factors that are responsible for it? Are there any remedial measures?

Factors are multi-rationale include the inappropriate use or unregulated use of high-end antibiotics in private practice. Besides that the patients discontinuing therapy midway i.e. not completing revommended treatment duration.

 

Previous 1 3 Next

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

GST

GST: Boon or Bane for Healthcare?

Send this article by email

X